Pascal Blanchet

2.7k total citations
57 papers, 1.2k citations indexed

About

Pascal Blanchet is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Pascal Blanchet has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 13 papers in Surgery and 12 papers in Molecular Biology. Recurrent topics in Pascal Blanchet's work include Prostate Cancer Diagnosis and Treatment (15 papers), Prostate Cancer Treatment and Research (15 papers) and Effects and risks of endocrine disrupting chemicals (7 papers). Pascal Blanchet is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (15 papers), Prostate Cancer Treatment and Research (15 papers) and Effects and risks of endocrine disrupting chemicals (7 papers). Pascal Blanchet collaborates with scholars based in France, Guadeloupe and Belgium. Pascal Blanchet's co-authors include Luc Multigner, Sylvaine Cordier, Marc Romana, Arnaud Giusti, Jean Pierre Thomé, S. Mallick, Bernard Jégou, A Jardin, G Benoît and Philippe Kadhel and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Environmental Health Perspectives.

In The Last Decade

Pascal Blanchet

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Blanchet France 19 504 251 212 196 176 57 1.2k
Jiří Heráček Czechia 20 617 1.2× 318 1.3× 347 1.6× 53 0.3× 201 1.1× 50 1.8k
Wen‐Yang Hu United States 19 180 0.4× 216 0.9× 472 2.2× 29 0.1× 199 1.1× 44 1.2k
Marie Navrátilová Czechia 18 150 0.3× 114 0.5× 306 1.4× 26 0.1× 142 0.8× 40 809
Hiromasa Tsukino Japan 20 176 0.3× 283 1.1× 471 2.2× 27 0.1× 178 1.0× 44 1.2k
Jin Wook Kim South Korea 18 261 0.5× 24 0.1× 349 1.6× 223 1.1× 58 0.3× 116 1.2k
Yu‐Chieh Tsai Taiwan 23 303 0.6× 142 0.6× 491 2.3× 51 0.3× 169 1.0× 58 1.3k
Pei‐Chien Tsai Taiwan 24 130 0.3× 331 1.3× 627 3.0× 29 0.1× 622 3.5× 78 2.0k
Sabah M. Quraishi United States 15 217 0.4× 305 1.2× 260 1.2× 13 0.1× 175 1.0× 24 1.4k
P. Christiansen Denmark 11 57 0.1× 699 2.8× 306 1.4× 87 0.4× 198 1.1× 20 1.9k
Gerald Sufrin United States 18 329 0.7× 54 0.2× 273 1.3× 69 0.4× 114 0.6× 46 930

Countries citing papers authored by Pascal Blanchet

Since Specialization
Citations

This map shows the geographic impact of Pascal Blanchet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Blanchet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Blanchet more than expected).

Fields of papers citing papers by Pascal Blanchet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Blanchet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Blanchet. The network helps show where Pascal Blanchet may publish in the future.

Co-authorship network of co-authors of Pascal Blanchet

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Blanchet. A scholar is included among the top collaborators of Pascal Blanchet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Blanchet. Pascal Blanchet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blanchet, Pascal, et al.. (2025). Prostate cancer as an occupational disease: the actual impact in a high-incidence area. PubMed. 35(9). 102933–102933.
2.
Cussenot, Olivier, Kirsten M. Timms, Pascal Blanchet, et al.. (2024). Tumour-based Mutational Profiles Predict Visceral Metastasis Outcome and Early Death in Prostate Cancer Patients. European Urology Oncology. 7(3). 597–604. 4 indexed citations
3.
Roger, Pierre‐Marie, et al.. (2023). Simplified antibiotic guidelines in urology are associated with decreased multidrug-resistant Enterobacterales. Infectious Diseases Now. 53(7). 104763–104763.
4.
Roger, Pierre‐Marie, et al.. (2022). Use of Antibiotic Prophylaxis for Polymicrobial Urine Culture before Urological Surgery: A Pilot Study. Urologia Internationalis. 106(12). 1272–1278. 1 indexed citations
5.
Antignac, Jean‐Philippe, Pascal Blanchet, F. Bruyère, et al.. (2022). Persistent organochlorine pesticides in periprostatic adipose tissue from men with prostate cancer: Ethno-geographic variations, association with disease aggressiveness. Environmental Research. 216(Pt 4). 114809–114809. 12 indexed citations
6.
Brureau, L., Luc Multigner, Freddie C. Hamdy, Pascal Blanchet, & Richard J. Bryant. (2021). Organochlorine pesticide exposure and risk of prostate cancer development and progression: a systematic review. F1000Research. 10. 262–262. 3 indexed citations
7.
Meunier, M, Pascal Blanchet, Y. Neuzillet, Thierry Lebrét, & Laurent Brureau. (2021). A review of new hormonal therapies for prostate cancer in black men: is there enough data?. BMC Cancer. 21(1). 61–61. 4 indexed citations
8.
Eyraud, Rémi, et al.. (2019). Biopsy Grade Group as a reliable prognostic factor for BCR in Afro-Caribbean men with intermediate- and high-risk prostate cancer. World Journal of Urology. 38(6). 1493–1499. 1 indexed citations
9.
Brureau, L., Nathalie Lemonne, Marie Billaud, et al.. (2016). Men with Sickle Cell Anemia and Priapism Exhibit Increased Hemolytic Rate, Decreased Red Blood Cell Deformability and Increased Red Blood Cell Aggregate Strength. PLoS ONE. 11(5). e0154866–e0154866. 28 indexed citations
10.
Patrikidou, Anna, L. Brureau, Laurence Albigès, et al.. (2015). Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome. Urologic Oncology Seminars and Original Investigations. 33(5). 202.e9–202.e17. 30 indexed citations
11.
Brureau, L., et al.. (2014). Copy Number Variation of GSTT1 and GSTM1 and the Risk of Prostate Cancer in a Caribbean Population of African Descent. PLoS ONE. 9(9). e107275–e107275. 17 indexed citations
12.
13.
Giton, Frank, Arnaud Giusti, Jean Fiet, et al.. (2013). Persistent Organochlorine Pollutants with Endocrine Activity and Blood Steroid Hormone Levels in Middle-Aged Men. PLoS ONE. 8(6). e66460–e66460. 16 indexed citations
14.
Lukacs, B., F. Bruyère, Pascal Blanchet, et al.. (2012). Photoselective Vaporization of the Prostate with GreenLight 120-W Laser Compared with Monopolar Transurethral Resection of the Prostate: A Multicenter Randomized Controlled Trial. European Urology. 61(6). 1165–1173. 127 indexed citations
15.
Mallick, S., Marc Romana, Pascal Blanchet, & Luc Multigner. (2007). GSTM1 and GSTT1 Polymorphisms and the Risk of Prostate Cancer in a Caribbean Population of African Descent. Urology. 69(6). 1165–1169. 26 indexed citations
16.
Mallick, S., Pascal Blanchet, & Luc Multigner. (2005). Prostate Cancer Incidence in Guadeloupe, a French Caribbean Archipelago. European Urology. 47(6). 769–772. 44 indexed citations
17.
18.
Paradis, Valérie, Ivan Bièche, Delphine Dargère, et al.. (2001). hTERT expression in sporadic renal cell carcinomas. The Journal of Pathology. 195(2). 209–217. 19 indexed citations
19.
Autiero, Monica, Raphaël Culerrier, Christiane Bouchier, et al.. (1999). Abnormal Restriction Pattern of PIP Gene Associated with Human Primary Prostate Cancers. DNA and Cell Biology. 18(6). 481–487. 9 indexed citations
20.
Paradis, Valérie, Ingrid Laurendeau, Annick Vieillefond, et al.. (1998). Clonal analysis of renal sporadic angiomyolipomas. Human Pathology. 29(10). 1063–1067. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiří Heráček Breakdown of academic impact, for papers by Wen‐Yang Hu Breakdown of academic impact, for papers by Marie Navrátilová Breakdown of academic impact, for papers by Hiromasa Tsukino Breakdown of academic impact, for papers by Jin Wook Kim Breakdown of academic impact, for papers by Yu‐Chieh Tsai Breakdown of academic impact, for papers by Pei‐Chien Tsai Breakdown of academic impact, for papers by Sabah M. Quraishi Breakdown of academic impact, for papers by P. Christiansen Breakdown of academic impact, for papers by Gerald Sufrin
Rankless by CCL
2026